Company News
Taysha Shares Fall 13% Post $200M Offering
Taysha Gene Therapies announced pricing of an underwritten public offering of 32.5 million shares at $6.00 each and pre‑funded warrants at $5.999.
The company expects gross proceeds of about $200 mill
